Glaucoma therapy and ocular surface disease: Current literature and recommendations

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

BAK-free and preservative-free therapies are becoming available but are not always a feasible alternative. It is important to recognize different clinical manifestations of allergy and chronic inflammation and to discuss options for patients experiencing OSD.

Original languageEnglish
Pages (from-to)136-143
Number of pages8
JournalCurrent Opinion in Ophthalmology
Volume24
Issue number2
DOIs
StatePublished - Mar 1 2013

Fingerprint

Eye Diseases
Glaucoma
Hypersensitivity
Inflammation
Therapeutics

Keywords

  • Benzalkonium Chloride
  • Glaucoma
  • Ocular Surface Disease
  • Preservatives
  • Recommendations

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Glaucoma therapy and ocular surface disease : Current literature and recommendations. / Anwar, Zane; Wellik, Sarah; Galor, Anat.

In: Current Opinion in Ophthalmology, Vol. 24, No. 2, 01.03.2013, p. 136-143.

Research output: Contribution to journalArticle

@article{a25345293b3447928b8e682a0a7fbe35,
title = "Glaucoma therapy and ocular surface disease: Current literature and recommendations",
abstract = "BAK-free and preservative-free therapies are becoming available but are not always a feasible alternative. It is important to recognize different clinical manifestations of allergy and chronic inflammation and to discuss options for patients experiencing OSD.",
keywords = "Benzalkonium Chloride, Glaucoma, Ocular Surface Disease, Preservatives, Recommendations",
author = "Zane Anwar and Sarah Wellik and Anat Galor",
year = "2013",
month = "3",
day = "1",
doi = "10.1097/ICU.0b013e32835c8aba",
language = "English",
volume = "24",
pages = "136--143",
journal = "Current Opinion in Ophthalmology",
issn = "1040-8738",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Glaucoma therapy and ocular surface disease

T2 - Current literature and recommendations

AU - Anwar, Zane

AU - Wellik, Sarah

AU - Galor, Anat

PY - 2013/3/1

Y1 - 2013/3/1

N2 - BAK-free and preservative-free therapies are becoming available but are not always a feasible alternative. It is important to recognize different clinical manifestations of allergy and chronic inflammation and to discuss options for patients experiencing OSD.

AB - BAK-free and preservative-free therapies are becoming available but are not always a feasible alternative. It is important to recognize different clinical manifestations of allergy and chronic inflammation and to discuss options for patients experiencing OSD.

KW - Benzalkonium Chloride

KW - Glaucoma

KW - Ocular Surface Disease

KW - Preservatives

KW - Recommendations

UR - http://www.scopus.com/inward/record.url?scp=84876210030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876210030&partnerID=8YFLogxK

U2 - 10.1097/ICU.0b013e32835c8aba

DO - 10.1097/ICU.0b013e32835c8aba

M3 - Article

C2 - 23542350

AN - SCOPUS:84876210030

VL - 24

SP - 136

EP - 143

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 2

ER -